Results for tag: "Nivolumab"

Nivolumab is a type of immunotherapy drug used to treat skin cancer. It is a monoclonal antibody that works by blocking the activity of a protein called PD-1, which helps cancer cells evade the body's immune system. Nivolumab is used to treat advanced melanoma, a type of skin cancer, and is approved for use in combination with other drugs. It is also being studied for use in other types of skin cancer, such as squamous cell carcinoma and basal cell carcinoma. Nivolumab is a relatively new drug, and is part of a growing class of immunotherapy drugs that are being used to treat cancer. It has been shown to be effective in treating advanced melanoma, and is being studied for use in other types of skin cancer. Some companies in the Nivolumab market include Bristol-Myers Squibb, Merck, and Roche. Show Less Read more